NASDAQ: RXRX · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Recursion Pharmaceuticals Inc.

How Recursion Pharmaceuticals Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.5B

Price

$4.24

P/E

-4.4

EPS (TTM)

$-0.97

1-year return

-27.8%

Dividend yield

0.0%

52-week range

$3.46–$4.36

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources